logo-loader
RNS
Craneware PLC

Dividend Currency Election

/**/ .h{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.h{}p.y{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";font-weight: bold; text-align: center; text-autospace: none}span.w{font-size:10.0pt;font-family:"Arial","sans-serif"}p.z{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";text-align:justify;text-autospace:none}p.aa{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";text-align:justify}span.t{font-size:10.0pt; font-family:"Arial","sans-serif";color:black}span.s{font-size:10.0pt;font-family:"Arial","sans-serif";color:black}span.q{font-size:10.0pt; font-family:"Arial","sans-serif"}p.a,li.a,div.a{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";} p.ab{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";font-weight: bold; text-align: justify}table.ac{width:468.0pt;margin-left:-10.8pt;border-collapse:collapse}td.o{width:84.45pt;padding:0cm 5.4pt 0cm 5.4pt}td.m{width:98.7pt;padding:0cm 5.4pt 0cm 5.4pt}span.n{font-size:9.0pt;font-family:"Arial","sans-serif"}td.l{width:91.95pt;padding:0cm 5.4pt 0cm 5.4pt}td.k{width:106.2pt;padding:0cm 5.4pt 0cm 5.4pt}span.j{font-size:9.0pt; font-family:"Arial","sans-serif"} /**/
RNS Number : 0679T
Craneware plc
15 March 2019
 

 

Craneware plc

("Craneware" or the "Company")

 

Dividend Currency Election

 

15 March 2019 - Craneware plc (AIM: CRW.L), the market leader in Value Cycle solutions for the US healthcare market, today gives further information regarding its final dividend announced on 5 March 2019.

 

For those shareholders who have previously registered to receive their dividend in US dollars under the Company's Dividend Currency Election, the dividend will be paid at an exchange rate of $1.32.

 

 

 

For further information, please contact:

 

Craneware plc

Peel Hunt          

Investec Bank

Alma

 

(NOMAD & Joint Broker)

(Joint Broker)

(Financial PR)

+44 (0)131 550 3100

+44 (0)20 7418 8900

+44 (0)20 7597 5970

+44 (0)203 405 0212

Keith Neilson, CEO

Dan Webster

Patrick Robb

Caroline Forde

Craig Preston, CFO

George Sellar

Sebastian Lawrence

Hilary Buchanan

 

Guy Pengelley

Henry Reast

Helena Bogle

 

About Craneware

Craneware develops and provides financial improvement & operational optimisation software that enables US healthcare providers to improve margins and enhance patient outcomes so they can continue to provide quality outcomes for all.

 

Craneware is the leader in automated Value Cycle solutions that help US Healthcare provider organisations discover, convert and optimise assets to achieve best clinical outcomes and financial performance. Founded in 1999, Craneware is headquartered in Edinburgh, Scotland with offices in Atlanta and Pittsburgh employing over 320 staff. Craneware's market-driven, SaaS solutions normalise disparate data sets, bringing in up-to-date regulatory and financial compliance data to deliver value at the points where clinical and operational data transform into financial transactions, creating actionable insights that enable informed tactical and strategic decisions. To learn more, visit craneware.com and thevaluecycle.com.

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCEALDSFLPNEFF

Quick facts: Craneware PLC

Price: £23.50

Market: AIM
Market Cap: £627.43 m
Follow

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

RNS

Director/PDMR Shareholding

2 days, 6 hours ago

Holding(s) in Company

4 days, 1 hour ago

Final Results

2 weeks, 3 days ago

Blocklisting Application

2 weeks, 4 days ago